Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | News item

PMDA: precautions should be revised for Covid-19 vaccine

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Myocarditis and pericarditis should be added to the precautions in the labelling for the coronavirus modified uridine RNA vaccine against Covid-19 (SARS-CoV-2), says Japan's PMDA.1
Fußnoten
1
SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2; PMDA = Pharmaceuticals and Medical Devices Agency
 
Metadaten
Titel
PMDA: precautions should be revised for Covid-19 vaccine
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-99700-x

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

BCG/mitomycin